0001590714-24-000011.txt : 20240122 0001590714-24-000011.hdr.sgml : 20240122 20240122173926 ACCESSION NUMBER: 0001590714-24-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240119 FILED AS OF DATE: 20240122 DATE AS OF CHANGE: 20240122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dorman Carey J. CENTRAL INDEX KEY: 0001770349 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36272 FILM NUMBER: 24550010 MAIL ADDRESS: STREET 1: C/O ELEMENT SOLUTIONS INC STREET 2: 383 MAIN AVENUE, 6TH FLOOR CITY: NORWALK STATE: CT ZIP: 06851 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Element Solutions Inc CENTRAL INDEX KEY: 0001590714 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 371744899 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 EAST BROWARD BOULEVARD STREET 2: SUITE 1860 CITY: FORT LAUDERDALE STATE: FL ZIP: 33394 BUSINESS PHONE: 561-207-9600 MAIL ADDRESS: STREET 1: 500 EAST BROWARD BOULEVARD STREET 2: SUITE 1860 CITY: FORT LAUDERDALE STATE: FL ZIP: 33394 FORMER COMPANY: FORMER CONFORMED NAME: Platform Specialty Products Corp DATE OF NAME CHANGE: 20131031 4 1 wk-form4_1705963157.xml FORM 4 X0508 4 2024-01-19 0 0001590714 Element Solutions Inc ESI 0001770349 Dorman Carey J. C/O ELEMENT SOLUTIONS INC 500 EAST BROWARD BOULEVARD, SUITE 1860 FORT LAUDERDALE FL 33394 0 1 0 0 EVP, CFO 0 Performance Stock Units 0 2024-01-19 4 A 0 35763 A Common Stock 35763 35763 D Restricted Stock Units 0 2024-01-19 4 A 0 17881 A Common Stock 17881 17881 D Each performance stock unit represents a contingent right to receive up to two shares of the Issuer's common stock, subject to the achievement of certain adjusted EBITDA compound annual growth and cash return on investment (CRI) goals for the performance period ending on December 31, 2026. The number of shares reported in Column 7 will range from zero to 71,526. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant will vest in 1/3 increments over the next three years. /s/ John E. Capps as Attorney-in-Fact for Carey J. Dorman 2024-01-22